Écrit par Teradata | 05 Mars 2016

L'utilisation d'analyses Big Data pour l'évaluation des risques par état pathologique afin d'améliorer la prise en charge du patient, de prévenir les maladies et de réduire les coûts




Antony, France,  le 4 mars 2016 - Cette nouvelle collaboration entre les leaders de l'analyse de données donnera un meilleur aperçu des risques liés aux patients et aidera sans doute à...

Écrit par GBI Research | 03 Mars 2016

NEW YORK (GBI Research), 3 March 2016 - The global adoption of telehealth technologies will potentially allow governments to make substantial savings on healthcare, while delivering important medical services to both rural and under-served communities, according to business intelligence provider GBI Research.



The company’s latest report* states that the telehealth market is being...

Écrit par Actinium Pharmaceuticals | 03 Mars 2016

CRO Selection Marks Significant Milestone Toward Start of Iomab-B Pivotal Trial

NEW YORK, NY - 03/02/16 - Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers announced today that it has selected Medpace as its Clinical Research Organization (CRO) for its...

Écrit par Amedica | 03 Mars 2016

Amedica's Silicon Nitride Performed 400% Better Than PEEK in Recent Cell Adhesion Study



SALT LAKE CITY, March 02, 2016 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce a collaboration with Celling Biosciences, a leader in autologous cellular therapy technologies...